Sphingadienes show therapeutic efficacy in neuroblastoma in vitro and in vivo by targeting the AKT signaling pathway.
| Author | |
|---|---|
| Year of Publication | :  2018 | 
| Journal | :  Investigational new drugs | 
| Date Published | :  2018 | 
| ISSN Number | :  0167-6997 | 
| DOI | :  10.1007/s10637-017-0558-5 | 
| Short Title | :  Invest New Drugs | 
| Download citation |